Strong Balance SheetLow leverage and a strong equity ratio give the company durable financial stability. This reduces refinancing risk, preserves borrowing capacity for capex or M&A, and provides a buffer in downturns, supporting long-term operational continuity and strategic optionality.

Positive Return On EquityA positive ROE indicates the business can generate returns from shareholder capital. Over months this supports reinvestment, dividend capacity or capital allocation flexibility and signals underlying economic profitability despite revenue volatility.

Stable/improving Operating MarginsSustained and slightly improving EBIT/EBITDA margins point to structural cost control or pricing power. Margin resilience cushions profit against revenue swings, preserves cash generation potential when top line recovers, and supports long-term earnings durability.

Bears Say

Declining RevenueA sharp recent revenue decline and inconsistent growth reduce scale and weaken competitive positioning. Persistently lower sales hinder fixed-cost absorption, limit reinvestment in product development or distribution, and make earnings recovery dependent on durable top-line improvement.

Negative Free Cash FlowNegative free cash flow constrains internal funding for working capital and capex, increases reliance on external financing, and limits the firm’s ability to pursue strategic investments. Over months this pressure can impede growth initiatives and raise funding costs.

Weak Cash ConversionLow conversion of earnings into cash signals earnings quality issues and exposure to working-capital swings. Even with reported profits, limited cash generation raises liquidity risk, reduces free cash for shareholders, and complicates sustained capital deployment plans.

Arvee Laboratories (India) Ltd. News

Arvee Laboratories to Shut Trading Window Ahead of December Quarter Results

Arvee Laboratories (India) Ltd. ( ($IN:ARVEE) ) has shared an announcement. Arvee Laboratories (India) Ltd has announced the...

2M ago

ARVEE

Arvee Laboratories Denies Any Undisclosed Events Behind Share Price Volatility

The latest update is out from Arvee Laboratories (India) Ltd. ( ($IN:ARVEE) ). Arvee Laboratories (India) Ltd. has...

2M ago

ARVEE

ARVEE FAQ

What was Arvee Laboratories (India) Ltd.’s price range in the past 12 months?

Arvee Laboratories (India) Ltd. lowest stock price was ₹133.40 and its highest was ₹290.78 in the past 12 months.

What is Arvee Laboratories (India) Ltd.’s market cap?

Arvee Laboratories (India) Ltd.’s market cap is ₹1.85B.

When is Arvee Laboratories (India) Ltd.’s upcoming earnings report date?

Arvee Laboratories (India) Ltd.’s upcoming earnings report date is May 22, 2026 which is in 90 days.

How were Arvee Laboratories (India) Ltd.’s earnings last quarter?

Arvee Laboratories (India) Ltd. released its earnings results on Feb 13, 2026. The company reported ₹1.658 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.658.

Is Arvee Laboratories (India) Ltd. overvalued?

According to Wall Street analysts Arvee Laboratories (India) Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Arvee Laboratories (India) Ltd. pay dividends?

Arvee Laboratories (India) Ltd. does not currently pay dividends.

What is Arvee Laboratories (India) Ltd.’s EPS estimate?

Arvee Laboratories (India) Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Arvee Laboratories (India) Ltd. have?

Arvee Laboratories (India) Ltd. has 11,020,000 shares outstanding.

What happened to Arvee Laboratories (India) Ltd.’s price movement after its last earnings report?

Arvee Laboratories (India) Ltd. reported an EPS of ₹1.658 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.977%.

Which hedge fund is a major shareholder of Arvee Laboratories (India) Ltd.?

Currently, no hedge funds are holding shares in IN:ARVEE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Arvee Laboratories (India) Ltd.

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company provides polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also offers drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino pyridine, and 2chloro5nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.